| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2673-2683. <i>Date of Electronic Publication: </i>2024 Apr 01.
- MeSH Terms: Diabetes Mellitus, Type 2* / complications ; Diabetes Mellitus, Type 2* / epidemiology ; Diabetic Angiopathies* / epidemiology ; Diabetic Angiopathies* / etiology ; Cardiovascular Diseases* / epidemiology ; Cardiovascular Diseases* / etiology ; Humans ; Male ; Female ; Prospective Studies ; Middle Aged ; United Kingdom / epidemiology ; Aged ; Adult ; Risk Factors ; Body Mass Index ; Smoking / adverse effects ; Smoking / epidemiology ; Glycated Hemoglobin / analysis ; Glycated Hemoglobin / metabolism ; Exercise ; Follow-Up Studies ; Blood Pressure ; Incidence
- References: GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203‐234. ; Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country‐level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. ; Cho Y, Park HS, Huh BW, et al. Prevalence and risk of diabetic complications in young‐onset versus late‐onset type 2 diabetes mellitus. Diabetes Metab. 2022;48(6):101389. ; Natarajan R. Epigenetic mechanisms in diabetic vascular complications and metabolic memory: the 2020 Edwin Bierman award lecture. Diabetes. 2021;70(2):328‐337. ; Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta‐analysis of 102 prospective studies. Lancet. 2010;375(9733):2215‐2222. ; Soyoye DO, Abiodun OO, Ikem RT, Kolawole BA, Akintomide AO. Diabetes and peripheral artery disease: a review. World J Diabetes. 2021;12(6):827‐838. ; Chen HY, Kuo S, Su PF, Wu JS, Ou HT. Health care costs associated with macrovascular, microvascular, and metabolic complications of type 2 diabetes across time: estimates from a population‐based cohort of more than 0.8 million individuals with up to 15 years of follow‐up. Diabetes Care. 2020;43(8):1732‐1740. ; Braffett BH, Gubitosi‐Klug RA, Albers JW, et al. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes. 2020;69(5):1000‐1010. ; Zelnick LR, Weiss NS, Kestenbaum BR, et al. Diabetes and CKD in the United States population, 2009‐2014. Clin J Am Soc Nephrol. 2017;12(12):1984‐1990. ; American Diabetes Association. 5. Lifestyle management: standards of medical care in diabetes‐2019. Diabetes Care. 2019;42(Suppl1):S46‐S60. ; Blomster JI, Chow CK, Zoungas S, et al. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2013;15(11):1008‐1012. ; Sun Z, Hu Y, Yu C, et al. Low‐risk lifestyle and health factors and risk of mortality and vascular complications in Chinese patients with diabetes. J Clin Endocrinol Metab. 2022;107(9):e3919‐e3928. ; Lloyd‐Jones DM, Allen NB, Anderson CAM, et al. Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18‐e43. ; Yi J, Wang L, Guo X, Ren X. Association of Life's essential 8 with all‐cause and cardiovascular mortality among US adults: a prospective cohort study from the NHANES 2005‐2014. Nutr Metab Cardiovasc Dis. 2023;33(6):1134‐1143. ; Petermann‐Rocha F, Deo S, Celis‐Morales C, et al. An opportunity for prevention: associations between the Life's essential 8 score and cardiovascular incidence using prospective data from UK biobank. Curr Probl Cardiol. 2023;48(4):101540. ; Sun J, Li Y, Zhao M, et al. Association of the American Heart Association's new "Life's essential 8" with all‐cause and cardiovascular disease‐specific mortality: prospective cohort study. BMC Med. 2023;21(1):116. ; He P, Li H, Ye Z, et al. Association of a healthy lifestyle, Life's essential 8 scores with incident macrovascular and microvascular disease among individuals with type 2 diabetes. J Am Heart Assoc. 2023;12(17):e029441. ; Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. ; Collins R. What makes UK biobank special? Lancet. 2012;379(9822):1173‐1174. ; Eastwood SV, Mathur R, Atkinson M, et al. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK biobank. PloS One. 2016;11(9):e0162388. ; Vetter C, Dashti HS, Lane JM, et al. Night shift work, genetic risk, and type 2 diabetes in the UK biobank. Diabetes Care. 2018;41(4):762‐769. ; Petermann‐Rocha F, Ho FK, Foster H, et al. Nonlinear associations between cumulative dietary risk factors and cardiovascular diseases, cancer, and all‐cause mortality: a prospective cohort study from UK biobank. Mayo Clin Proc. 2021;96(9):2418‐2431. ; Clavel J, Merceron G, Escarguel G. Missing data estimation in morphometrics: how much is too much? Syst Biol. 2014;63(2):203‐218. ; Xing A, Tian X, Wang Y, et al. 'Life's essential 8′ cardiovascular health with premature cardiovascular disease and all‐cause mortality in young adults: the Kailuan prospective cohort study. Eur J Prev Cardiol. 2023;30(7):593‐600. ; Wang T, Lu J, Su Q, et al. Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4(9):874‐883. ; Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3276. ; Makarem N, Castro‐Diehl C, St‐Onge MP, et al. Redefining cardiovascular health to include sleep: prospective associations with cardiovascular disease in the MESA sleep study. J Am Heart Assoc. 2022;11(21):e025252. ; Stehouwer CDA. Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences. Diabetes. 2018;67(9):1729‐1741. ; Geng T, Zhu K, Lu Q, et al. Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: a cohort study. PLoS Med. 2023;20(1):e1004135. ; Liu G, Li Y, Pan A, et al. Adherence to a healthy lifestyle in association with microvascular complications among adults with type 2 diabetes. JAMA Netw Open. 2023;6(1):e2252239. ; Durlach V, Vergès B, Al‐Salameh A, et al. Smoking and diabetes interplay: a comprehensive review and joint statement. Diabetes Metab. 2022;48(6):101370. ; Ding N, Sang Y, Chen J, et al. Cigarette smoking, smoking cessation, and long‐term risk of 3 major atherosclerotic diseases. J Am Coll Cardiol. 2019;74(4):498‐507. ; Yang Y, Peng N, Chen G, et al. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events. Cardiovasc Diabetol. 2022;21(1):14. ; Avogaro A, Fadini GP. Microvascular complications in diabetes: a growing concern for cardiologists. Int J Cardiol. 2019;291:29‐35. ; UK Prospective Diabetes Study (UKPDS) Group. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837‐853. ; Nellaiappan K, Preeti K, Khatri DK, Singh SB. Diabetic complications: an update on pathobiology and therapeutic strategies. Curr Diabetes Rev. 2022;18(1):e030821192146. ; Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 2007;9(6):781‐791. ; Dunkler D, Dehghan M, Teo KK, et al. Diet and kidney disease in high‐risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013;173(18):1682‐1692. ; Sone H, Tanaka S, Tanaka S, et al. Leisure‐time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan diabetes complications study (JDCS). Diabetologia. 2013;56(5):1021‐1030. ; Kebbe M, Gao M, Perez‐Cornago A, Jebb SA, Piernas C. Adherence to international dietary recommendations in association with all‐cause mortality and fatal and non‐fatal cardiovascular disease risk: a prospective analysis of UK biobank participants. BMC Med. 2021;19(1):134.
- Grant Information: 2022A1515011920 Basic and Applied Basic Research Foundation of Guangdong Province; 2023A1515011730 Basic and Applied Basic Research Foundation of Guangdong Province; 81900379 National Natural Science Foundation of China; 81970683 National Natural Science Foundation of China; 82170457 National Natural Science Foundation of China; 82371573 National Natural Science Foundation of China
- Contributed Indexing: Keywords: Life's Essential 8; cardiovascular health; type 2 diabetes; vascular complications
- Substance Nomenclature: 0 (Glycated Hemoglobin)
- Entry Date(s): Date Created: 20240401 Date Completed: 20240604 Latest Revision: 20240604
- Update Code: 20240604
|
